Graybug Vision Stock (NASDAQ:GRAY)


$ 1.20
Today's Range
$1.17 - $1.28
52-Week Range
$1.05 - $7.06
Market Cap

About Graybug Vision (NASDAQ:GRAY)

(NASDAQ:GRAY) Graybug Vision, Inc., a clinical stage biopharmaceutical company, develops medicines for the treatment of diseases of the retina and optic nerve. Its lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the treatment of wet age-related macular degeneration, as well as in Phase IIa clinical trial to treat diabetic macular edema. The company is also developing GB-103, a once-a-year formulation of GB-102, for the treatment of diabetic retinopathy; and GB-401, a depot formulation of a beta-adrenergic receptor inhibitor to treat primary open-angle glaucoma. The company was formerly known as Graybug LLC and changed its name to Graybug Vision, Inc. in 2016. Graybug Vision, Inc. was founded in 2011 and is based in Redwood City, California.
Show more

GRAY Stock Price

Statistics Highlights (NASDAQ:GRAY)

Shares Outstanding 21.36M Beta -
Public Float 10.23M P/E Ratio -
% Short of Float - Dividend (Yield) -
Held by Insiders 7.67% Ex-Dividend Date
Held by Institutions 53.10% IPO Date Sep 25, 2020

GRAY Financial Summary

Dec 21 Dec 20 Dec 19
Revenue $0.00 $0.00 $0.00
EBITDA $-35.95M $-29.44M $-37.20M
Net Income $-35.82M $-27.53M $-37.04M
Total Assets $69.09M $101.79M $40.66M
Total Cash $13.36M $33.42M $15.87M
Total Debt $ $ $
Dec 21 Sep 21 Jun 21
Revenue $0.00 $0.00 $0.00
EBITDA $-10.05M $-7.88M $-7.61M
Net Income $-8.68M $-7.99M $-7.71M
Total Assets $69.09M $76.64M $82.82M
Total Cash $13.36M $11.45M $7.86M
Total Debt $ $ $

GRAY Stock Price History

Graybug Vision Annual Stock Price History

Year Open Close Change
2022 $1.70 $1.20 -29.41%
2021 $27.65 $1.70 -93.85%

Graybug Vision Daily Stock Price History

Date Open High Low Close Change Volume
May 17, 2022 $0.88 $0.92 $0.82 $0.90 1.34% 32.34K
May 16, 2022 $0.89 $0.99 $0.88 $0.89 7.80% 42.13K

(NASDAQ:GRAY) Stock Price FAQs

What is today's stock price of Graybug Vision (NASDAQ:GRAY)?

  • The current stock price of Graybug Vision (NASDAQ:GRAY) is $1.20.
  • Today GRAY stock price opened at $1.24 after previous close of $1.17.
  • During the day, Graybug Vision stock quote has varied from a low of $1.17 to a high of $1.28.

What is Graybug Vision's 52-week change?

  • GRAY 52-week high stock quote is $7.06, which is 488.30% above the current share price.
  • The Graybug Vision (NASDAQ:GRAY) 52-week low stock price is $1.05, which is 12.50% below the current share price.

Is Graybug Vision a buy?

  • According to 5 analysts, the current consensus recommendation for Graybug Vision stock is "Strong Buy" at an average rating score of 4.60 (out of 5).
  • There are currently 3 "Strong Buy", 2 "Buy", 0 "Hold", 0 "Sell", and 0 "Strong Sell" analysts recommendations for the GRAY stock.
  • The 12 month average price target forecast for GRAY stock is $35.00, representing a 2816.70% increase from the current GRAY stock price of $1.20.

Graybug Vision (NASDAQ:GRAY) FAQ

How Much is Graybug vision Worth?

Graybug vision's worth today based on market capitalisation is $25.63M

How much dividend does Graybug vision Pay?

The current annualized dividend payout for GRAY stock is $0.00, the dividend yield is 0.00% and the payout ratio is 0.00%.
View More Details on Graybug vision's "Dividend" Section

What is Graybug vision’s Price to Earning (PE) ratio?

GRAY stock also has a Price to Sales (P/S) ratio of 0.00.

What is the Graybug vision's ticker?

Graybug vision trades on the NASDAQ stock market in USA under the ticker symbol "GRAY". Graybug vision’s stock symbol can also be displayed as "NASDAQ:GRAY".

When did GRAY go public?

Graybug vision completed its initial public offering (IPO) on September 25 ,2020.

Who are the owners of Graybug vision?

Graybug vision (NASDAQ:GRAY) is owned by 53.10% institutional shareholders and by 7.67% insiders. The rest is owned by the public.
The 3 top institutional shareholders are "Deerfield Management Co", "Orbimed Advisors, LLC" and "Vanguard Group Inc", representing 46.24% of Graybug vision’s total shares outstanding.
Explore More Details on Graybug vision's “Ownership” Section

Who are the key executives of Graybug vision (GRAY)?

Graybug vision's key executive team includes the following managers:

  • Dr. Frederic Guerard Pharm.D., Pres, CEO & Director (1972)
  • Mr. Robert S. Breuil, Chief Financial Officer (1962)
  • Dr. Gerald D. Cagle Ph.D., Sr. Advisor, Head of Bus. Devel. & Director (1944)
  • Dr. Parisa Zamiri M.D., Ph.D., Chief Medical Officer (1965)
  • Dr. Peter A. Campochiaro M.D., Co-Founder (NA)
  • Dr. Peter J. McDonnell, Co-Founder (1959)
  • Ms. Bettina Maunz, Chief People Officer & Head of Communications (NA)
  • Mr. Ming Yang, Sr. VP of R&D (NA)
  • Dr. Ward M. Peterson Ph.D., Sr. VP of Preclinical Devel. (NA)
  • Mr. Ali Kakavand, VP & Head of Program Management (NA)

What is Graybug vision’s Sector & Industry Classification?

Graybug vision (NASDAQ:GRAY) is classified under the "Healthcare" sector and under the "Biotechnology" industry.

How many employees work for Graybug vision?

Currently the number of employees working for Graybug vision is 27.

Where are Graybug vision's Headquarters?

Graybug vision (NASDAQ:GRAY) is headquartered in CA, United States.

What are Graybug vision's Address and Phone Number?

Graybug vision’s mailing address is 203 Redwood Shores Parkway, Redwood City, CA, United States, 94065.
The company’s phone number is 650 487 2800.

What is the official website for Graybug vision?

Graybug vision’s official website is